Search database
LIST OPTIONS
Filter
24
Filtered Results: 24
Text search: Shinar, S.
Featured
Language
Document type
No document type
18
Studies & Reports
2
Guidelines
2
Manuals
1
Videos
1
Countries / Regions
Indonesia
6
Chile
2
Kazakhstan
1
Africa
1
Latin America and the Carribbean
1
Germany
1
Uganda
1
South Sudan
1
Liberia
1
Authors & Publishers
World Health Organization WHO
4
et al.
3
World Health Organization
3
Ministry of Health Republic of Indonesia
2
WHO
2
A. Arzimanoglou
1
Association of Indonesian Continents
1
Benson-Martin, J.
1
Biddle, L.
1
C. Acevedo
1
C. Perplies
1
CDC
1
Indonesian Rheumatology Association
1
Indonesian Society of Internal Medicine
1
International Bureau for Epilepsy
1
International League against Epilepsy
1
International League Against Epilepsy (UK Chapter) and Epilepsy Society
1
Kestel, D., et al.
1
Mews, C.
1
mhGAP
1
Ministerio de Salud - Chile
1
Ministerio de Salud de Chile
1
National AIDS Commission of Liberia
1
Neligan, A. & Sander, J.W.
1
Pan American Health Organization (PAHO)
1
R. S. Fisher
1
Rahardjo, H.E., B.I. Santoso, S. Hakim, et al.,
1
Science for Non-Scientist
1
Scott F. Dowell, James J. Sejvar, Lul Riek, et al.
1
Shinar, S.
1
Springer International Publishing
1
World Health Organization (WHO)
1
Publication Years
Category
Countries
10
Public Health
1
Toolboxes
Mental Health
9
Refugee
1
Disability
1
Caregiver
1
Global Health Education
1
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World Health Organization (WHO), the World Bank and the Harvard School of Public Health, drew the attention of the international health community to the burden of neurological disorders and many other chronic conditions. T... more
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?

Global Campaign Against Epilepsy

World Health Organization; International League against Epilepsy; International Bureau for Epilepsy (2003) C_WHO
Out of the shadows
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?